Synthesis of novel series of 3,5-disubstituted imidazo[1,2-
Journal
RSC advances
ISSN: 2046-2069
Titre abrégé: RSC Adv
Pays: England
ID NLM: 101581657
Informations de publication
Date de publication:
16 Feb 2022
16 Feb 2022
Historique:
received:
27
09
2021
accepted:
07
02
2022
entrez:
15
4
2022
pubmed:
16
4
2022
medline:
16
4
2022
Statut:
epublish
Résumé
The first access to 3,5-disubstituted imidazo[1,2-
Identifiants
pubmed: 35424561
doi: 10.1039/d1ra07208k
pii: d1ra07208k
pmc: PMC8981913
doi:
Types de publication
Journal Article
Langues
eng
Pagination
6303-6313Informations de copyright
This journal is © The Royal Society of Chemistry.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Eur J Med Chem. 2015 May 5;95:514-25
pubmed: 25847769
J Org Chem. 2017 Dec 15;82(24):13700-13707
pubmed: 29131628
J Med Chem. 2005 Apr 7;48(7):2266-9
pubmed: 15801818
Eur J Med Chem. 2015 Aug 28;101:205-17
pubmed: 26141911
J Org Chem. 2016 Aug 5;81(15):6573-9
pubmed: 27379380
Org Lett. 2006 Oct 12;8(21):4811-3
pubmed: 17020309
J Cardiovasc Pharmacol. 1991;18 Suppl 10:S1-6
pubmed: 1724996
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1712-1726
pubmed: 32962435
J Org Chem. 2005 Aug 5;70(16):6230-41
pubmed: 16050682
J Org Chem. 2017 Jun 2;82(11):5898-5903
pubmed: 28494581
J Org Chem. 2013 Jul 19;78(14):7337-42
pubmed: 23786601